Alpha-1 Antitrypsin Deficiency (AATD): Open Clinical Trials

1 protocols meet the specified criteria

OCR21902

A Placebo-Controlled, Multi-dose, Phase 2/3 Study to Determine the Safety, Tolerability and Effect on Liver Histologic Parameters in Response to ARO-AAT in Patients With Alpha-1 Antitrypsin Deficiency (AATD)